The optimal treatment of STEMI: new pharmacological and device approaches.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.

Original languageEnglish (US)
Pages (from-to)339-343
Number of pages5
JournalPanminerva Medica
Volume55
Issue number4
StatePublished - 2013

Fingerprint

Pharmacology
Equipment and Supplies
Mortality
Therapeutics
Epidemiologic Studies
Cardiovascular Diseases
ST Elevation Myocardial Infarction

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The optimal treatment of STEMI : new pharmacological and device approaches. / Movahed, Mohammad R.

In: Panminerva Medica, Vol. 55, No. 4, 2013, p. 339-343.

Research output: Contribution to journalArticle

@article{063313ca219445cb8614e771faf82a58,
title = "The optimal treatment of STEMI: new pharmacological and device approaches.",
abstract = "Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.",
author = "Movahed, {Mohammad R}",
year = "2013",
language = "English (US)",
volume = "55",
pages = "339--343",
journal = "Panminerva Medica",
issn = "0031-0808",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - The optimal treatment of STEMI

T2 - new pharmacological and device approaches.

AU - Movahed, Mohammad R

PY - 2013

Y1 - 2013

N2 - Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.

AB - Cardiovascular disease remains the leading cause of mortality worldwide. Many deaths are contributed to acute ST elevation myocardial infarction (STEMI). Recently, epidemiological studies have been shown reduction in STEMI related mortality over the last decade. This reduction has partially been attributed to new pharmacological and device advances that were utilized during STEMI treatment. The goal of this manuscript is to review new pharmacological and device approaches available in the treatment of STEMI patients.

UR - http://www.scopus.com/inward/record.url?scp=84903878290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903878290&partnerID=8YFLogxK

M3 - Article

C2 - 24434342

AN - SCOPUS:84903878290

VL - 55

SP - 339

EP - 343

JO - Panminerva Medica

JF - Panminerva Medica

SN - 0031-0808

IS - 4

ER -